🇺🇸 FDA
Patent

US 6686338

Enzyme inhibitors for metabolic redirection

expired A61KA61K31/337A61K38/00

Quick answer

US patent 6686338 (Enzyme inhibitors for metabolic redirection) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/337, A61K38/00